cgp 20712a and xamoterol

cgp 20712a has been researched along with xamoterol in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	2 (40.00)	18.2507
2000's	1 (20.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Baker, JG; Fischer, PM; Gardiner, SM; Hill, SJ; Kellam, B; Mistry, SN	1
Bals, S; Brodde, OE; Deighton, NM; Motomura, S; Zerkowski, HR	1
Carson, PE	1
Karle, CA; Kathöfer, S; Kiehn, J; Schoels, W; Zhang, W; Zitron, E	1
Baker, JG; Fretwell, L; Gardiner, SM; Hill, SJ; Kemp, P; March, J	1

Reviews

1 review(s) available for cgp 20712a and xamoterol

Article	Year
Beta-blocker therapy in heart failure: pathophysiology and clinical results. Current problems in cardiology, 1999, Volume: 24, Issue:7 Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol	1999

Article

Year

Beta-blocker therapy in heart failure: pathophysiology and clinical results.

Current problems in cardiology, 1999, Volume: 24, Issue:7

Topics: Adrenergic beta-Antagonists; Aged; Bisoprolol; Carbazoles; Carvedilol; Clinical Trials as Topic; Exercise; Heart Failure; Heart Rate; Hemodynamics; Humans; Imidazoles; Male; Metoprolol; Middle Aged; Propanolamines; Propranolol; Quality of Life; Stroke Volume; Time Factors; Vasodilator Agents; Xamoterol

1999

Other Studies

4 other study(ies) available for cgp 20712a and xamoterol

Article	Year
Synthesis and in vitro and in vivo characterization of highly β1-selective β-adrenoceptor partial agonists. Journal of medicinal chemistry, 2013, May-23, Volume: 56, Issue:10 Topics: Adrenergic beta-1 Receptor Agonists; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Drug Design; Heart Rate; Hemodynamics; Humans; Indicators and Reagents; Ligands; Male; Propanolamines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Structure-Activity Relationship	2013
Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium. The Journal of pharmacology and experimental therapeutics, 1992, Volume: 262, Issue:2 Topics: Adrenergic beta-Agonists; Adult; Aged; Calcium; Deoxyepinephrine; Dobutamine; Dopamine; Ethanolamines; Female; Heart Atria; Humans; Imidazoles; In Vitro Techniques; Male; Middle Aged; Myocardial Contraction; Propanolamines; Stimulation, Chemical; Xamoterol	1992
Rapid component I(Kr) of the guinea-pig cardiac delayed rectifier K(+) current is inhibited by beta(1)-adrenoreceptor activation, via cAMP/protein kinase A-dependent pathways. Cardiovascular research, 2002, Feb-01, Volume: 53, Issue:2 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbazoles; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Depression, Chemical; Enzyme Inhibitors; Guinea Pigs; Imidazoles; Indoles; Isoproterenol; Myocardium; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Pyrroles; Xamoterol	2002
Predicting in vivo cardiovascular properties of β-blockers from cellular assays: a quantitative comparison of cellular and cardiovascular pharmacological responses. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2011, Volume: 25, Issue:12 Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiovascular Agents; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Heart Rate; Humans; Imidazoles; Isoproterenol; Male; Phenoxyacetates; Phenoxypropanolamines; Propanolamines; Rats; Rats, Sprague-Dawley; Vascular Resistance; Xamoterol	2011